Argos Therapeutics | Crunchbase Argos Therapeutics, Inc., a biotechnology company, engages in developing immunotherapy treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. The company has clinical trial programs in cancer and human immunodeficiency virus. Argos Therapeutics Inc. (fka ARGSQ) Message Board ... Sep 25, 2019 · The company also develops AGS-003 for metastatic renal cell carcinoma (non-clear cell), early stage RCC, and other solid tumors. The company was formerly known as Merix Bioscience, Inc. and changed its name to Argos Therapeutics, Inc. in October 2004. Argos Therapeutics, Inc. was founded in 1997 and is headquartered in Durham, North Carolina
13 Nov 2017 An interim analysis that sank hopes for Argos Therapeutics Inc.'s for futility, the company's stock plummeted more than 63% to $1.60 apiece.
(ARGS) - Business Finance, Stock Market, Quotes, News The requested symbol was not found in our database. Try searching for some other symbol on Yahoo Finance OTC:ARGS / Argos Therapeutics, Inc. - SEC Filings, 10K, 8K ... ARGS / Argos Therapeutics, Inc. - 8-K - Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant 05-03 sec.gov - 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2019 Argos … ARGS Stock News and Price / Argos Therapeutics, Inc ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
(ARGS) - Business Finance, Stock Market, Quotes, News The requested symbol was not found in our database. Try searching for some other symbol on Yahoo Finance OTC:ARGS / Argos Therapeutics, Inc. - SEC Filings, 10K, 8K ... ARGS / Argos Therapeutics, Inc. - 8-K - Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant 05-03 sec.gov - 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2019 Argos …
Dec 19, 2016 · Argos Therapeutics, Inc.ARGS was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too …
Here's What's Dragging Argos Therapeutics (ARGS) Stock ...
Get today's Argos Therapeutics Inc stock price and latest ARGSQ news as well as Argos Therapeutics real-time stock quotes, technical analysis, full financials
Sep 07, 2017 · The news did little to reverse the direction of ARGS stock as it continues to languish around all-time lows. The stock is currently trading in a tight $0.21 – $0.25 per share range. Argos Therapeutics Inc (NASDAQ:ARGS) has underperformed the overall industry having shed more than 80% in market value since the start of the year. Argos Therapeutics (ARGS) Dividends | The Motley Fool Real time Argos Therapeutics (ARGS) Dividends. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. ARGS - Argos Therapeutics News - Barchart.com